Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Rheumatology (Oxford, England)
|
May 10, 2025
The incidence of anti-HMGCR immune-mediated necrotising myopathy: an Australian and UK retrospective multi-site cohort study
Thomas Khoo, Elina Tan, Vidya Limaye, et al.
Plos One
|
April 11, 2023
Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial
Sophia G Connor, Timothy J Fairchild, Yvonne C Learmonth, et al.
The Journal of Rheumatology
|
February 17, 2019
OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies
Malin Regardt, Christopher A Mecoli, Jin Kyun Park, et al.
Seminars in Arthritis and Rheumatism
|
September 9, 2020
Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group
Tina Esfandiary, Jin Kyun Park, Helene Alexanderson, et al.
Seminars in Arthritis and Rheumatism
|
August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group
Ellen Romich, Didem Saygin, Dana DiRenzo, et al.
Seminars in Arthritis and Rheumatism
|
June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group
Didem Saygin, Helene Alexanderson, Dana DiRenzo, et al.
European Journal of Human Genetics : EJHG
|
January 28, 2016
Prominent scapulae mimicking an inherited myopathy expands the phenotype of CHD7-related disease
Gina L O'Grady, Alan Ma, Deborah Sival, et al.
Seminars in Arthritis and Rheumatism
|
November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group
Dana DiRenzo, Didem Saygin, Ingrid de Groot, et al.
Journal of Neuromuscular Diseases
|
November 18, 2016
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA
Mark A Price, Victoria Barghout, Olivier Benveniste, et al.
Clinical and Experimental Rheumatology
|
March 4, 2024
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
Didem Saygin, Stefanie Glaubitz, Rachel Zeng, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Rheumatology (Oxford, England)
|
May 10, 2025
The incidence of anti-HMGCR immune-mediated necrotising myopathy: an Australian and UK retrospective multi-site cohort study
Thomas Khoo, Elina Tan, Vidya Limaye, et al.
Plos One
|
April 11, 2023
Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trial
Sophia G Connor, Timothy J Fairchild, Yvonne C Learmonth, et al.
The Journal of Rheumatology
|
February 17, 2019
OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies
Malin Regardt, Christopher A Mecoli, Jin Kyun Park, et al.
Seminars in Arthritis and Rheumatism
|
September 9, 2020
Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group
Tina Esfandiary, Jin Kyun Park, Helene Alexanderson, et al.
Seminars in Arthritis and Rheumatism
|
August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group
Ellen Romich, Didem Saygin, Dana DiRenzo, et al.
Seminars in Arthritis and Rheumatism
|
June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group
Didem Saygin, Helene Alexanderson, Dana DiRenzo, et al.
European Journal of Human Genetics : EJHG
|
January 28, 2016
Prominent scapulae mimicking an inherited myopathy expands the phenotype of CHD7-related disease
Gina L O'Grady, Alan Ma, Deborah Sival, et al.
Seminars in Arthritis and Rheumatism
|
November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group
Dana DiRenzo, Didem Saygin, Ingrid de Groot, et al.
Journal of Neuromuscular Diseases
|
November 18, 2016
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA
Mark A Price, Victoria Barghout, Olivier Benveniste, et al.
Clinical and Experimental Rheumatology
|
March 4, 2024
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
Didem Saygin, Stefanie Glaubitz, Rachel Zeng, et al.
Page
of 12